Baldomero, Arianne K.
MacDonald, David M.
Kaplan, Adam
Lock, Eric
Cho, Michael H.
Bowler, Russell
Gillenwater, Lucas
Kunisaki, Ken M.
Wendt, Chris H.
Funding for this research was provided by:
National Center for Advancing Translational Sciences,United States (KL2TR002492)
National Center for Advancing Translational Sciences (UL1TR002494)
National Heart, Lung, and Blood Institute (2T32HL007741)
Article History
Received: 7 November 2022
Accepted: 7 June 2023
First Online: 20 July 2023
Declarations
:
: Written informed consent for participation in COPDGene was obtained from all subjects, and the study was approved by institutional review boards at all each of the 21 participating centers prior to study initiation: National Jewish Health, HS-1883a; Brigham and Women’s Hospital, 2007-P-000554/2; Baylor College of Medicine, H-22209; Michael E. DeBakey VAMC, H − 22202; Columbia University Medical Center, IRB-AAAC9324; Duke University Medical Center, Pro00004464; Johns Hopkins University, NA_00011524; Los Angeles Biomedical Research Institute, 12756–01; Morehouse School of Medicine, 07–1029; Temple University, 11369; University of Alabama at Birmingham, FO70712014; University of California, San Diego, 070876; University of Iowa, 200710717; Ann Arbor VA, PCC 2008–110732; University of Minnesota, 0801 M24949; University of Pittsburgh, RO07120059; University of Texas Health Sciences Center at San Antonio, HSC20070644H; Health Partners Research Foundation, 07–127; University of Michigan, HUM00014973; Minneapolis VA Medical Center, 4128-A; Fallon Clinic, 1143.
: Not applicable.
: KMK reports personal fees from Nuvaira and Organicell (Data Safety and Monitoring Boards) and Allergan/AbbVie (Consulting). The remaining authors have nothing to declare.
: The views expressed in this article are those of the authors and do not reflect the views of the United States Government, the Department of Veterans Affairs, the National Institutes of Health, the funders, the sponsors, or any of the author’s affiliated academic institution.